Muscle Invasive Bladder Cancer Overview

Save information for later
Sign Up

Learn About Muscle Invasive Bladder Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Muscle Invasive Bladder Cancer Local Doctors?
Elite in Muscle Invasive Bladder Cancer
Elite in Muscle Invasive Bladder Cancer

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English

Ashish Kamat is an Urologist in Houston, Texas. Dr. Kamat is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

Elite in Muscle Invasive Bladder Cancer
Elite in Muscle Invasive Bladder Cancer

Temple Faculty Practice Plan Inc

502 Centennial Blvd, 
Voorhees, NJ 
Languages Spoken:
English
Offers Telehealth

Alexander Kutikov is an Urologist in Voorhees, New Jersey. Dr. Kutikov is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Bladder Cancer, Nephrectomy, and Cystectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Muscle Invasive Bladder Cancer
General Surgery | Urology
Elite in Muscle Invasive Bladder Cancer
General Surgery | Urology

Temple Faculty Practice Plan Inc

3509 N Broad St, 
Philadelphia, PA 
Languages Spoken:
English

Marc Smaldone is a General Surgeon and an Urologist in Philadelphia, Pennsylvania. Dr. Smaldone is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Cystectomy.

What are the latest Muscle Invasive Bladder Cancer Clinical Trials?
A Phase II Trial of Futibatinib in Combination With Durvalumab (MEDI4736) Administered to Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer Before Cystectomy

Summary: This phase II trial tests how well the combination of futibatinib and durvalumab given before cystectomy works in treating patients with muscle-invasive bladder cancer (MIBC) who are ineligible for cisplatin-based therapy. Cisplatin-based therapy is the standard of care for patients with MIBC. However, many patients cannot receive standard therapy due to poor renal function, peripheral neuropathy,...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Single Arm Phase II Study of Bladder Preservation With Immunoradiotherapy After a Clinically Meaningful Response to Neoadjuvant Therapy in Patients With Muscle Invasive Bladder Cancer (BRIGHT)

Summary: This phase II trial tests the effect of giving pembrolizumab in combination with radiation therapy after chemotherapy in preventing surgery to remove the bladder in patients with muscle invasive bladder cancer. Standard of care therapy includes chemotherapy before surgery (neoadjuvant) to shrink or get rid of the tumor. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the ...